BMC Genomics (Apr 2012)

The stable traits of melanoma genetics: an alternate approach to target discovery

  • Spivey Tara L,
  • De Giorgi Valeria,
  • Zhao Yingdong,
  • Bedognetti Davide,
  • Pos Zoltan,
  • Liu Qiuzhen,
  • Tomei Sara,
  • Ascierto Maria,
  • Uccellini Lorenzo,
  • Reinboth Jennifer,
  • Chouchane Lotfi,
  • Stroncek David F,
  • Wang Ena,
  • Marincola Francesco M

DOI
https://doi.org/10.1186/1471-2164-13-156
Journal volume & issue
Vol. 13, no. 1
p. 156

Abstract

Read online

Abstract Background The weight that gene copy number plays in transcription remains controversial; although in specific cases gene expression correlates with copy number, the relationship cannot be inferred at the global level. We hypothesized that genes steadily expressed by 15 melanoma cell lines (CMs) and their parental tissues (TMs) should be critical for oncogenesis and their expression most frequently influenced by their respective copy number. Results Functional interpretation of 3,030 transcripts concordantly expressed (Pearson's correlation coefficient p-value MITF, melanoma differentiation antigens, and displayed a Th1 immune phenotype associated with better prognosis and likelihood to respond to immunotherapy. An intermediate third class (C) was further identified. The three phenotypes were confirmed by unsupervised principal component analysis. Conclusions This study suggests that clinically relevant phenotypes of melanoma can be retraced to stable oncogenic properties of cancer cells linked to their genetic back bone, and offers a roadmap for uncovering novel targets for tailored anti-cancer therapy.

Keywords